ZHOU Xu, WEI Yuan-yuan, MA Tao, TANG Yue-zhou, DANG Yun-jie, CAO De-ying. Physiological pharmacokinetic model of children and its application of modeling softwareJ. Acta Pharmaceutica Sinica, 2023, 58(2): 320-329. DOI: 10.16438/j.0513-4870.2022-1124
Citation: ZHOU Xu, WEI Yuan-yuan, MA Tao, TANG Yue-zhou, DANG Yun-jie, CAO De-ying. Physiological pharmacokinetic model of children and its application of modeling softwareJ. Acta Pharmaceutica Sinica, 2023, 58(2): 320-329. DOI: 10.16438/j.0513-4870.2022-1124

Physiological pharmacokinetic model of children and its application of modeling software

  • Developmental changes in children can affect drug disposition and clinical effects. A physiologically-based pharmacokinetic (PBPK) model is a mathematical model that can be used to predict blood drug concentrations in children and gain insight into age-dependent physiological differences in drug disposition impact. Pediatric PBPK (P-PBPK) models have attracted attention over the past decade. With the concerted efforts of academia, pharmaceutical companies, and regulatory agencies, there are more and more examples of pediatric clinical studies using PBPK models. Nevertheless, the number of P-PBPK models and their predictive performance still lag behind adult models. By referring to the literature, we study the process of children adapting to adult absorption, distribution, metabolism, and excretion (ADME) parameters and analyze the general principles of P-PBPK model establishment. In addition, we summarize the functions and application examples of commonly used P-PBPK modeling software to provide a basis for the rational application of modeling software.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return